Formulation and Evaluation of Mouth Dissolving Tablets of Montelukast sodium

  • Arindam Chatterjee Associate Professor, Jaipur College of Pharmacy, Jaipur, Rajasthan, India
  • Bharat J. Vaghela Plant Head, Sunrise Remedies Pvt. Ltd. Santej Teh Kalol Dist. Gandhi Nagar, Gujarat
  • Rakesh Kumar Gupta Professor, Jaipur College of Pharmacy, Jaipur, Rajasthan, India
  • Ombir Research Scholar, Jaipur College of Pharmacy, Jaipur, Rajasthan, India
DOI: https://doi.org/10.32553/jbpr.v11i2.908
Keywords: Montelukast sodium, Mouth Dissolving Tablets, Direct Compression, in-vitro dissolution.

Abstract

The present study aims to formulate mouth dissolving tablets of montelukast sodium by direct compression method for the faster action, better absorption and improvement of bioavailability of the drug in management of Asthma. Total six formulations were developed with varying concentrations of combination of Crosspovidone and Sodium starch glycolate as super disintegrating agents. The tablets were prepared by direct compression method. The prepared MDT were evaluated for various parameters i.e. shape and size, weight variation, thickness, hardness, friability, wetting time, disintegration time, drug content, dissolution test, accelerated stability studies etc. After comparing the results (particularly disintegration time and dissolution profile), it was concluded that formulation TF3 was selected as the best formulation among all.

Keywords: Montelukast sodium, Mouth Dissolving Tablets, Direct Compression, in-vitro dissolution.

Published
2022-04-29
How to Cite
Chatterjee, A., Vaghela, B. J., Gupta, R. K., & Ombir. (2022). Formulation and Evaluation of Mouth Dissolving Tablets of Montelukast sodium. Journal of Biomedical and Pharmaceutical Research, 11(2). https://doi.org/10.32553/jbpr.v11i2.908
Issue
Vol. 11 No. 2 (2022)
Section
Articles

Copyright (c) 2022 Journal of Biomedical and Pharmaceutical Research

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Creative Commons LicenseJournal of Biomedical and Pharmaceutical Research by Articles is licensed under a Creative Commons Attribution 4.0 International License.